The Stroke Prevention Policy Model: Linking Evidence and Clinical Decisions

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Annals of Internal Medicine

• Publication date

  1997-10-15

• Fields of study

  Medicine, Political Science

• Identifiers
  DOI 10.7326/0003-4819-127-8_Part_2-199710151-00054PMID 9382384
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke.

  1999cited by this paper
• Quantification and the quest for medical certainty

  1997cited by this paper
• Assessing Uncertainty in Cost-Effectiveness Analyses

  1997cited by this paper
• Decision Models in Clinical Recommendations Development : the Stroke Prevention Policy

  1996cited by this paper
• Lifetime cost of stroke in the United States.

  1996cited by this paper
• Identifying and Valuing Outcomes

  1996cited by this paper
• Evidence based medicine: what it is and what it isn't

  1996cited by this paper
• Is Risk Neutrality Rational?

  1996cited by this paper
• Recommendations of the Panel on Cost-effectiveness in Health and Medicine.

  1996cited by this paper
• Comparison and meta‐analysis of randomized trials of endarterectomy for symptomatic carotid artery stenosis

  1995cited by this paper
• Medical Treatment for Stroke Prevention

  1994cited by this paper
• Knowing and acting in medical practice: the epistemological politics of outcomes research.

  1994cited by this paper
• Cost of Stroke

  1993cited by this paper
• Use of Claims Data to Monitor Patients over Time: Acute Myocardial Infarction as a Case Study a

  1993cited by this paper
• Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

  1991cited by this paper
• Probability of stroke: a risk profile from the Framingham Study.

  1991cited by this paper
• Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis.

  1991cited by this paper
• Methodologic issues in policy modeling for cardiovascular disease.

  1989cited by this paper
• Cost-effectiveness analysis of patient management alternatives after uncomplicated myocardial infarction: a model.

  1987cited by this paper
• A theory of requisite decision models

  1984cited by this paper
• Screening for cancer : theory, analysis, and design

  1984cited by this paper
• The social transformation of american medicine.

  1983cited by this paper
• XXXIX. The haze of Bayes, the aerial palaces of decision analysis, and the computerized Ouija board

  1977cited by this paper
• Personal Knowledge: Towards a Post-Critical Philosophy

  1959cited by this paper
• Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis

  1957cited by this paper

• Prognostic Significance of DNA Topoisomerase II Alpha (TOP2A) in Cholangiocarcinoma.

  2023cites this paper
• Microsimulation Model Using Christiana Care Early Warning System (CEWS) to Evaluate Physiological Deterioration

  2019cites this paper
• A protocol for an economic evaluation of a polypill in patients with established or at high risk of cardiovascular disease in a UK NHS setting: RUPEE (NHS) study

  2018cites this paper
• Operations research models for investigation and improvement of the hyperacute stroke care system

  2017cites this paper
• Linked Sensitivity Analysis, Calibration, and Uncertainty Analysis Using a System Dynamics Model for Stroke Comparative Effectiveness Research

  2016cites this paper
• Development of a Microsimulation Model to Predict Stroke and Long-Term Mortality in Adherent and Nonadherent Medically Managed and Surgically Treated Octogenarians with Asymptomatic Significant Carotid Artery Stenosis.

  2016cites this paper
• Stroke care systems: Can simulation modeling catch up with the recent advances in stroke treatment?

  2015cites this paper
• Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2.

  2012cites this paper
• Comparative effectiveness and implementation research: Directions for Neurology

  2012cites this paper
• Conceptualizing a Model

  2012cites this paper
• Dynamic Microsimulation Models for Health Outcomes

  2011cites this paper
• Cost Effectiveness Analysis in Healthcare Decision-Making: Stochastic Modeling and Statistical Inference.

  2011cites this paper
• Draft -conceptual Modeling: a Report of the Ispor-smdm Modeling Good Research Practices Task Force Working Group -part 2

  2011cites this paper
• Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.

  2011cites this paper
• resource utilisation in Europe disease: a multinational long term study of Direct costs of glaucoma and severity of the

  2010cites this paper
• Model-based cost-effectiveness analyses for the treatment of acute stroke events: a review and summary of challenges.

  2009cites this paper
• Costs of Stroke Using Patient-Level Data: A Critical Review of the Literature

  2009cites this paper
• The Contrast and Convergence of Bayesian and Frequentist Statistical Approaches in Pharmacoeconomic Analysis

  2007cites this paper
• Use of dynamic microsimulation to predict disease progression in patients with pneumonia-related sepsis

  2007cites this paper
• The Cost-Effectiveness and Cost-Benefit of Screening and Brief Intervention for Unhealthy Alcohol Use in Medical Settings

  2007cites this paper
• Preventing another event: role of the hospitalist in discharge stroke prevention.

  2007cites this paper
• A model for undertaking effectiveness and cost-effectiveness analyses of primary preventive strategies in cardiovascular disease

  2006cites this paper
• A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma.

  2006cites this paper
• The Impact of Patient Self-Testing of Prothrombin Time for Managing Anticoagulation: Rationale and Design of VA Cooperative Study #481—The Home INR Study (THINRS)

  2005cites this paper
• Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe

  2005cites this paper
• Development and application of Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS): An Australian economic model for stroke

  2005cites this paper
• Cost-effectiveness of antiplatelet agents in secondary stroke prevention: the limits of certainty.

  2005cites this paper
• Combining Information From Multiple Data Sources to Create Multivariable Risk Models: Illustration and Preliminary Assessment of a New Method

  2005cites this paper
• Bayesian Approaches to Clinical Trials and Health-Care Evaluation: Spiegelhalter/Clinical Trials and Health-Care Evaluation

  2004cites this paper
• Validation of a decision model for preventive pharmacological strategies in postmenopausal women

  2004cites this paper
• Editorial comment--what can models teach us about stroke treatment? Sorting out the missing bits.

  2004cites this paper
• Disease Mapping With WinBUGS and MLwiN, Bayesian Approaches to Clinical Trials and Health Care Evaluation

  2004cites this paper
• Mitochondrial uncoupling as a potential therapeutic target in acute central nervous system injury

  2004cites this paper
• Comprehensive decision analytical modelling in economic evaluation: a Bayesian approach.

  2004cites this paper
• A Bayesian Approach to Net Health Benefits: An Illustration and Application to Modeling HIV Prevention

  2004cites this paper
• Cost-Effectiveness of Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke Assessed by a Model Based on UK NHS Costs

  2004cites this paper
• Survey methods in stroke medicine

  2003cites this paper
• Case Scenarios to Assess Australian General Practitioners’ Understanding of Stroke Diagnosis, Management, and Prevention

  2003cites this paper
• Entscheidungsanalytische Evaluationen gesundheitsökonomischer Endpunkte von Interventionen bei koronarer Herzkrankheit — Definitionen, Methoden und Fallbeispiele

  2003cites this paper
• Cross-Calibration of Stroke Disability Measures

  2003cites this paper
• Cost-effectiveness and decision analysis research in stroke

  2003cites this paper
• Development of a decision-analytic model of stroke care in the United States and Europe.

  2002cites this paper
• Empirically calibrated model of hepatitis C virus infection in the United States.

  2002cites this paper
• UKPDS 60: Risk of Stroke in Type 2 Diabetes Estimated by the UK Prospective Diabetes Study Risk Engine

  2002cites this paper
• Measuring uncertainty in complex decision analysis models

  2002cites this paper
• The role of decision-analytic models in the prevention, diagnosis and treatment of coronary heart disease

  2002cites this paper
• Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section

  2002cites this paper
• Cost-effectiveness of ancrod treatment of acute ischaemic stroke: results from the Stroke Treatment with Ancrod Trial (STAT).

  2002cites this paper
• Supplemental oxygen use in ischemic stroke patients: does utilization correspond to need for oxygen therapy?

  2002cites this paper
• A Bayesian approach to net health benefits: an illustration and application to modeling HIV prevention.

  2002cites this paper
• First aid: lessons from health economics for economic evaluation in social welfare

  2002cites this paper
• Economic Evaluation in Stroke Research

  2001cites this paper
• Economic evaluation in stroke research. An introduction.

  2001cites this paper
• Evidence-based medicine as Bayesian decision-making.

  2000cites this paper
• Thrombolysis in the Treatment of Acute Ischaemic Stroke

  2000cites this paper
• Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis.

  2000cites this paper
• Bayesian methods in health technology assessment: a review.

  2000cites this paper
• Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke.

  1999cites this paper
• Using outcomes data to identify best medical practice: the role of policy models.

  1999cites this paper
• An Analysis of Optimal Resource Allocation for Prevention of Infection with Human Immunodeficiency Virus (HIV) in Injection Drug Users and Non-Users

  1999cites this paper
• Practice guidelines and tort reform: the legal system confronts the technocratic wish.

  1999cites this paper
• A systematic review of cost-effectiveness research of stroke evaluation and treatment.

  1999cites this paper
• Outcomes research in critical care: results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. The Members of the Outcomes Research Workshop.

  1999cites this paper
• Stroke treatment economic model (STEM): predicting long-term costs from functional status.

  1999cites this paper
• Predicting Long-Term Costs From Functional Status

  1999cites this paper
• Results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research

  1999cites this paper
• Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke.

  1998cites this paper
• The future of scientific medicine.

  1998cites this paper
• The Role of Information Technology in Disease Management: Supporting Identification and Delivery of Best Practices

  1998cites this paper
• The value of stroke prevention and treatment

  1998cites this paper
• Shortcomings of the randomized controlled trial: a view from the boondocks.

  1998cites this paper
• The contribution of multiple data sources to a clinical audit of lymphoma in a teaching hospital.

  1998cites this paper
• Assessing Uncertainty in Cost-Effectiveness Analyses

  1997cites this paper